Katacine
CAS No. 135151-34-7
Katacine( —— )
Catalog No. M17252 CAS No. 135151-34-7
Katacine inhibits of oxygen consumption and suppresses the speed of electrons transfer from oxidation substrates via respiratory chain of mitochondria to molecular oxygen.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 122 | In Stock |
|
| 5MG | 236 | In Stock |
|
| 10MG | 433 | In Stock |
|
| 25MG | 708 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKatacine
-
NoteResearch use only, not for human use.
-
Brief DescriptionKatacine inhibits of oxygen consumption and suppresses the speed of electrons transfer from oxidation substrates via respiratory chain of mitochondria to molecular oxygen.
-
DescriptionKatacine inhibits of oxygen consumption and suppresses the speed of electrons transfer from oxidation substrates via respiratory chain of mitochondria to molecular oxygen.Katacine is a mixture of polymers of A-type proanthocyanidins at various stages of polymerisation , from Polygonum coriarium of the Polygonaceae family. Katacine is an antihypoxic.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
Targetc-Kit
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number135151-34-7
-
Formula Weight——
-
Molecular Formula(C15H13O7)-[C15H12O7]n-(C15H13O7)
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
BLU-263
BLU-263 is an investigational, potent, and selective oral small molecule inhibitor of KIT with sub-nanomolar potency against D816V-mutant KIT.
-
Avapritinib
Avapritinib (BLU-285) is a potent and highly selective inhibitor of mutant KIT and PDGFRα with IC50 of 0.6, 0.27 and 0.24 nM for KIT del557-558, KIT D816V and PDGFRA D842V, respectively.
-
DCC-2618
DCC-2618 (Ripretinib, DCC2618) is a potent, oral inhibitor of singly and doubly mutated KIT with IC50 of WT (IC50=4 nM), V654A (8 nM), T670I (18 nM), D816H (5 nM).
Cart
sales@molnova.com